...
首页> 外文期刊>Vaccine >Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.
【24h】

Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.

机译:MF59辅助流感疫苗的交叉保护:针对A(H3N2)漂移的流感病毒的中和抑制血凝反应的抗体活性。

获取原文
获取原文并翻译 | 示例

摘要

Adjuvants enhance antibody response against vaccination. We compared the ability of MF59-adjuvanted and non-adjuvanted subunit influenza vaccines, containing A/Wyoming/3/03(H3N2), to confer cross-protection against four consecutive drifted strains in the elderly. Neutralizing and haemagglutination-inhibiting antibody were measured. MF59-adjuvanted vaccine induced a stronger booster response against A/Panama/2007/99(H3N2) than non-adjuvanted vaccine. A/Panama/2007/99(H3N2) circulated widely during the previous 5 years and was included in vaccines over four consecutive seasons. Broader serological protection against drifted strains that circulated 1 and 2 years after vaccination with A/Wyoming/3/03(H3N2) was observed with MF59-adjuvanted vaccine. Thus, MF59-adjuvanted vaccine confers greater immunogenicity than non-adjuvanted vaccines in vulnerable populations.
机译:佐剂增强针对疫苗的抗体应答。我们比较了含有A / Wyoming / 3/03(H3N2)的MF59佐剂型和非佐剂型亚单位流感疫苗针对老年人中四个连续漂移株的交叉保护能力。测量中和和抑制血凝反应的抗体。 MF59佐剂疫苗比非佐剂疫苗对A / Panama / 2007/99(H3N2)的诱导作用更强。 A / Panama / 2007/99(H3N2)在过去5年中广泛流传,并已连续四个赛季被纳入疫苗。用MF59佐剂疫苗接种A / Wyoming / 3/03(H3N2)疫苗后1年和2年流传的变种菌株具有更广泛的血清学保护作用。因此,在弱势人群中,MF59佐剂疫苗比非佐剂疫苗具有更大的免疫原性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号